The quarterly cost of dupilumab would have to drop from $7311 to $2038.50 for the biologic to be cost effective relative to tCS and to $302.55 to be cost effective relative to PPI therapy, ...

Dupilumab is effective for atopic dermatitis, ... “Due to its high cost and multiple indications, tier placement of dupilumab must take many factors into consideration,” they noted.

Learn about side effects, cost, and more of Dupixent (dupilumab). It’s a prescription drug that treats atopic dermatitis (a type of eczema) and other conditions.

Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and ...

If approved, potential barriers to the use of dupilumab in practice include cost and insurance coverage, education and dissemination of study findings, and limited data on side effects, said Narendra.

"[W]hether dupilumab is better than the good old topical glucocorticoids in improving disease outcomes, particularly in light of considerable costs associated with [dupilumab] treatment, remains ...

additional costs applied to non-responders to account for the cost of treatment failure (see section 3.12). When taking into account the confidential discount for dupilumab, the company's base-case ...

Dupilumab (Dupixent), a medicine that you get as a shot, is the first new treatment for CSU in the U.S. in over a decade. It’s already used to treat different inflammation conditions in the U.S ...

Since its release in 2017, dupilumab (a fully humanized monoclonal antibody that blocks IL-4 and IL-13) has transformed the therapeutic landscape for managing atopic dermatitis (AD) and other ...